Deanna Bracy, B.S.

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice. Kang L, Mayes WH, James FD, Bracy DP, Wasserman DH (2014) Diabetologia 57(3): 603-13
   › Primary publication · 24305966 (PubMed) · PMC4155606 (PubMed Central)
2. Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal stem cell therapy in the infarcted heart. Hughey CC, James FD, Ma L, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Shearer J (2014) Am J Physiol Cell Physiol 306(1): C19-27
   › Primary publication · 24196528 (PubMed) · PMC3919976 (PubMed Central)
3. FGF19 action in the brain induces insulin-independent glucose lowering. Morton GJ, Matsen ME, Bracy DP, Meek TH, Nguyen HT, Stefanovski D, Bergman RN, Wasserman DH, Schwartz MW (2013) J Clin Invest 123(11): 4799-808
   › Primary publication · 24084738 (PubMed) · PMC3809800 (PubMed Central)
4. Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Hughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Hittel DS, Shearer J (2013) Cardiovasc Diabetol : 128
   › Primary publication · 24007410 (PubMed) · PMC3847505 (PubMed Central)
5. Relaxin treatment reverses insulin resistance in mice fed a high-fat diet. Bonner JS, Lantier L, Hocking KM, Kang L, Owolabi M, James FD, Bracy DP, Brophy CM, Wasserman DH (2013) Diabetes 62(9): 3251-60
   › Primary publication · 23801576 (PubMed) · PMC3749347 (PubMed Central)
6. Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance. Kang L, Lantier L, Kennedy A, Bonner JS, Mayes WH, Bracy DP, Bookbinder LH, Hasty AH, Thompson CB, Wasserman DH (2013) Diabetes 62(6): 1888-96
   › Primary publication · 23349492 (PubMed) · PMC3661617 (PubMed Central)
7. Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Bonner JS, Lantier L, Hasenour CM, James FD, Bracy DP, Wasserman DH (2013) Diabetes 62(2): 572-80
   › Primary publication · 23002035 (PubMed) · PMC3554359 (PubMed Central)
8. Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor. Burmeister MA, Bracy DP, James FD, Holt RM, Ayala J, King EM, Wasserman DH, Drucker DJ, Ayala JE (2012) J Physiol 590(20): 5245-55
   › Primary publication · 22890715 (PubMed) · PMC3497575 (PubMed Central)
9. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Wu L, Parekh VV, Gabriel CL, Bracy DP, Marks-Shulman PA, Tamboli RA, Kim S, Mendez-Fernandez YV, Besra GS, Lomenick JP, Williams B, Wasserman DH, Van Kaer L (2012) Proc Natl Acad Sci U S A 109(19): E1143-52
   › Primary publication · 22493234 (PubMed) · PMC3358828 (PubMed Central)
10. Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. Ayala JE, Bracy DP, Malabanan C, James FD, Ansari T, Fueger PT, McGuinness OP, Wasserman DH (2011) J Vis Exp (57)
    › Primary publication · 22126863 (PubMed) · PMC3308587 (PubMed Central)
11. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance. Ayala JE, Bracy DP, James FD, Burmeister MA, Wasserman DH, Drucker DJ (2010) Endocrinology 151(10): 4678-87
    › Primary publication · 20685876 (PubMed) · PMC2946144 (PubMed Central)
12. Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo. Lee-Young RS, Ayala JE, Hunley CF, James FD, Bracy DP, Kang L, Wasserman DH (2010) Am J Physiol Regul Integr Comp Physiol 298(5): R1399-408
    › Primary publication · 20200137 (PubMed) · PMC2867517 (PubMed Central)
13. Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. Lee-Young RS, Griffee SR, Lynes SE, Bracy DP, Ayala JE, McGuinness OP, Wasserman DH (2009) J Biol Chem 284(36): 23925-34
    › Primary publication · 19525228 (PubMed) · PMC2781986 (PubMed Central)
14. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Ayala JE, Bracy DP, James FD, Julien BM, Wasserman DH, Drucker DJ (2009) Endocrinology 150(3): 1155-64
    › Primary publication · 19008308 (PubMed) · PMC2654733 (PubMed Central)
15. Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle. Shearer J, Fueger PT, Wang Z, Bracy DP, Wasserman DH, Rottman JN (2008) Biochim Biophys Acta 1782(10): 586-92
    › Primary publication · 18692568 (PubMed)
16. Insulin action in the double incretin receptor knockout mouse. Ayala JE, Bracy DP, Hansotia T, Flock G, Seino Y, Wasserman DH, Drucker DJ (2008) Diabetes 57(2): 288-97
    › Primary publication · 17977951 (PubMed)
17. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II. Fueger PT, Lee-Young RS, Shearer J, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH (2007) Diabetes 56(10): 2476-84
    › Primary publication · 17639019 (PubMed)
18. Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter. Fueger PT, Li CY, Ayala JE, Shearer J, Bracy DP, Charron MJ, Rottman JN, Wasserman DH (2007) J Physiol 582(Pt 2): 801-12
    › Primary publication · 17495042 (PubMed) · PMC2075340 (PubMed Central)
19. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH (2007) Diabetes 56(4): 1025-33
    › Primary publication · 17229936 (PubMed)
20. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH (2006) Diabetes 55(2): 390-7
    › Primary publication · 16443772 (PubMed)
21. Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Shearer J, Fueger PT, Bracy DP, Wasserman DH, Rottman JN (2005) Diabetes 54(11): 3133-9
    › Primary publication · 16249436 (PubMed)
22. Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. Fueger PT, Shearer J, Krueger TM, Posey KA, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH (2005) J Physiol 566(Pt 2): 533-41
    › Primary publication · 15878951 (PubMed) · PMC1464755 (PubMed Central)
23. Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice. Fueger PT, Shearer J, Bracy DP, Posey KA, Pencek RR, McGuinness OP, Wasserman DH (2005) J Physiol 562(Pt 3): 925-35
    › Primary publication · 15576451 (PubMed) · PMC1665542 (PubMed Central)
24. Control of exercise-stimulated muscle glucose uptake by GLUT4 is dependent on glucose phosphorylation capacity in the conscious mouse. Fueger PT, Hess HS, Posey KA, Bracy DP, Pencek RR, Charron MJ, Wasserman DH (2004) J Biol Chem 279(49): 50956-61
    › Primary publication · 15456776 (PubMed)
25. Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise. Shearer J, Fueger PT, Rottman JN, Bracy DP, Binas B, Wasserman DH (2005) Am J Physiol Endocrinol Metab 288(2): E292-7
    › Primary publication · 15454399 (PubMed)
26. Regulation of insulin-stimulated muscle glucose uptake in the conscious mouse: role of glucose transport is dependent on glucose phosphorylation capacity. Fueger PT, Hess HS, Bracy DP, Pencek RR, Posey KA, Charron MJ, Wasserman DH (2004) Endocrinology 145(11): 4912-6
    › Primary publication · 15284204 (PubMed)
27. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. Shearer J, Fueger PT, Rottman JN, Bracy DP, Martin PH, Wasserman DH (2004) Am J Physiol Endocrinol Metab 287(5): E871-7
    › Primary publication · 15265760 (PubMed)
28. AMP kinase-induced skeletal muscle glucose but not long-chain fatty acid uptake is dependent on nitric oxide. Shearer J, Fueger PT, Vorndick B, Bracy DP, Rottman JN, Clanton JA, Wasserman DH (2004) Diabetes 53(6): 1429-35
    › Primary publication · 15161745 (PubMed)
29. Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Granner DK, Wasserman DH (2004) Diabetes 53(2): 306-14
    › Primary publication · 14747279 (PubMed)
30. Quinides of roasted coffee enhance insulin action in conscious rats. Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, Graham TE, Wasserman DH (2003) J Nutr 133(11): 3529-32
    › Primary publication · 14608069 (PubMed)
31. Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Wasserman DH (2004) Am J Physiol Endocrinol Metab 286(1): E77-84
    › Primary publication · 13129858 (PubMed)
32. Hexokinase II partial knockout impairs exercise-stimulated glucose uptake in oxidative muscles of mice. Fueger PT, Heikkinen S, Bracy DP, Malabanan CM, Pencek RR, Laakso M, Wasserman DH (2003) Am J Physiol Endocrinol Metab 285(5): E958-63
    › Primary publication · 12865258 (PubMed)
33. Fiber type-specific determinants of Vmax for insulin-stimulated muscle glucose uptake in vivo. Petersen HA, Fueger PT, Bracy DP, Wasserman DH, Halseth AE (2003) Am J Physiol Endocrinol Metab 284(3): E541-8
    › Primary publication · 12556351 (PubMed)
34. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Rottman JN, Bracy D, Malabanan C, Yue Z, Clanton J, Wasserman DH (2002) Am J Physiol Endocrinol Metab 283(1): E116-23
    › Primary publication · 12067851 (PubMed)
35. Functional limitations to glucose uptake in muscles comprised of different fiber types. Halseth AE, Bracy DP, Wasserman DH (2001) Am J Physiol Endocrinol Metab 280(6): E994-9
    › Primary publication · 11350781 (PubMed)
36. Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Halseth AE, Bracy DP, Wasserman DH (2000) Am J Physiol Endocrinol Metab 279(5): E1064-71
    › Primary publication · 11052961 (PubMed)
37. Role of Ca(2+) fluctuations in L6 myotubes in the regulation of the hexokinase II gene. Halseth AE, O'Doherty RM, Printz RL, Bracy DP, Granner DK, Wasserman DH (2000) J Appl Physiol (1985) 88(2): 669-73
    › Primary publication · 10658036 (PubMed)
38. Effect of fast duration on disposition of an intraduodenal glucose load in the conscious dog. Galassetti P, Hamilton KS, Gibbons FK, Bracy DP, Lacy DB, Cherrington AD, Wasserman DH (1999) Am J Physiol 276(3 Pt 1): E543-52
    › Primary publication · 10070022 (PubMed)
39. Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo. Halseth AE, Bracy DP, Wasserman DH (1999) Am J Physiol 276(1 Pt 1): E70-7
    › Primary publication · 9886952 (PubMed)
40. Limitations to exercise- and maximal insulin-stimulated muscle glucose uptake. Halseth AE, Bracy DP, Wasserman DH (1998) J Appl Physiol (1985) 85(6): 2305-13
    › Primary publication · 9843557 (PubMed)
41. Analysis of insulin-stimulated skeletal muscle glucose uptake in conscious rat using isotopic glucose analogs. O'Doherty RM, Halseth AE, Granner DK, Bracy DP, Wasserman DH (1998) Am J Physiol 274(2 Pt 1): E287-96
    › Primary publication · 9486160 (PubMed)
42. Role of hepatic alpha- and beta-adrenergic receptor stimulation on hepatic glucose production during heavy exercise. Coker RH, Krishna MG, Lacy DB, Bracy DP, Wasserman DH (1997) Am J Physiol 273(5 Pt 1): E831-8
    › Primary publication · 9374667 (PubMed)
43. Gut and liver fat metabolism in depancreatized dogs: effects of exercise and acute insulin infusion. Namdaran K, Bracy DP, Lacy DB, Johnson JL, Bupp JL, Wasserman DH (1997) J Appl Physiol (1985) 83(4): 1339-47
    › Primary publication · 9338445 (PubMed)
44. Transcription of the rat skeletal muscle hexokinase II gene is increased by acute exercise. O'Doherty RM, Bracy DP, Granner DK, Wasserman DH (1996) J Appl Physiol (1985) 81(2): 789-93
    › Primary publication · 8872647 (PubMed)
45. Gut proteolysis contributes essential amino acids during exercise. Williams BD, Wolfe RR, Bracy DP, Wasserman DH (1996) Am J Physiol 270(1 Pt 1): E85-90
    › Primary publication · 8772478 (PubMed)
46. Effect of prior exercise on the partitioning of an intestinal glucose load between splanchnic bed and skeletal muscle. Hamilton KS, Gibbons FK, Bracy DP, Lacy DB, Cherrington AD, Wasserman DH (1996) J Clin Invest 98(1): 125-35
    › Primary publication · 8690783 (PubMed) · PMC507408 (PubMed Central)
47. Regulation of glucose uptake and metabolism by working muscle. An in vivo analysis. Zinker BA, Lacy DB, Bracy D, Jacobs J, Wasserman DH (1993) Diabetes 42(7): 956-65
    › Primary publication · 8513977 (PubMed)
48. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. McGuinness OP, Fugiwara T, Murrell S, Bracy D, Neal D, O'Connor D, Cherrington AD (1993) Am J Physiol 265(2 Pt 1): E314-22
    › Primary publication · 8368302 (PubMed)
49. Role of glucose and insulin loads to the exercising limb in increasing glucose uptake and metabolism. Zinker BA, Lacy DB, Bracy DP, Wasserman DH (1993) J Appl Physiol (1985) 74(6): 2915-21
    › Primary publication · 8365992 (PubMed)
50. Regulation of gluconeogenesis during rest and exercise in the depancreatized dog. Wasserman DH, Johnson JL, Bupp JL, Lacy DB, Bracy DP (1993) Am J Physiol 265(1 Pt 1): E51-60
    › Primary publication · 8338154 (PubMed)
51. Relationship between arterial and portal vein immunoreactive glucagon during exercise. Wasserman DH, Lacy DB, Bracy DP (1993) J Appl Physiol (1985) 75(2): 724-9
    › Primary publication · 8226475 (PubMed)
52. Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog. McGuinness OP, Burgin K, Moran C, Bracy D, Cherrington AD (1994) Am J Physiol 266(3 Pt 1): E438-47
    › Primary publication · 8166265 (PubMed)
53. Rat skeletal muscle hexokinase II mRNA and activity are increased by a single bout of acute exercise. O'Doherty RM, Bracy DP, Osawa H, Wasserman DH, Granner DK (1994) Am J Physiol 266(2 Pt 1): E171-8
    › Primary publication · 8141274 (PubMed)
54. Sensitivity of exercise-induced increase in hepatic glucose production to glucose supply and demand. Berger CM, Sharis PJ, Bracy DP, Lacy DB, Wasserman DH (1994) Am J Physiol 267(3 Pt 1): E411-21
    › Primary publication · 7943221 (PubMed)
55. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog. McGuinness OP, Murrell S, Moran C, Bracy D, Cherrington AD (1994) Metabolism 43(10): 1310-7
    › Primary publication · 7934986 (PubMed)
56. Impact of suprapharmacological androgenic steroid administration on basal and insulin-stimulated glucose and amino acid metabolism. Wasserman DH, Ruzumna PA, Bracy DP, Lacy DB, Boothe HW, Williams PE, Abumrad NN (1994) Metabolism 43(10): 1266-74
    › Primary publication · 7934979 (PubMed)
57. Exercise-induced fall in insulin: mechanism of action at the liver and effects on muscle glucose metabolism. Zinker BA, Mohr T, Kelly P, Namdaran K, Bracy DP, Wasserman DH (1994) Am J Physiol 266(5 Pt 1): E683-9
    › Primary publication · 7911275 (PubMed)
58. Carbohydrate metabolism during exercise: influence of circulating fat availability. Bracy DP, Zinker BA, Jacobs JC, Lacy DB, Wasserman DH (1995) J Appl Physiol (1985) 79(2): 506-13
    › Primary publication · 7592210 (PubMed)
59. Exercise-induced rise in glucagon and ketogenesis during prolonged muscular work. Wasserman DH, Spalding JA, Bracy D, Lacy DB, Cherrington AD (1989) Diabetes 38(6): 799-807
    › Primary publication · 2566546 (PubMed)
60. Hepatic nerves are not essential to the increase in hepatic glucose production during muscular work. Wasserman DH, Williams PE, Lacy DB, Bracy D, Cherrington AD (1990) Am J Physiol 259(2 Pt 1): E195-203
    › Primary publication · 2200275 (PubMed)
61. Interaction of exercise and insulin action in humans. Wasserman DH, Geer RJ, Rice DE, Bracy D, Flakoll PJ, Brown LL, Hill JO, Abumrad NN (1991) Am J Physiol 260(1 Pt 1): E37-45
    › Primary publication · 1987792 (PubMed)
62. Efficiency of compensation for absence of fall in insulin during exercise. Wasserman DH, Lacy DB, Colburn CA, Bracy D, Cherrington AD (1991) Am J Physiol 261(5 Pt 1): E587-97
    › Primary publication · 1951683 (PubMed)
63. Glucoregulation during rest and exercise in depancreatized dogs: role of the acute presence of insulin. Wasserman DH, Bupp JL, Johnson JL, Bracy D, Lacy DB (1992) Am J Physiol 262(5 Pt 1): E574-82
    › Primary publication · 1590369 (PubMed)
64. Metabolic regulation in peripheral tissues and transition to increased gluconeogenic mode during prolonged exercise. Wasserman DH, Lacy DB, Bracy D, Williams PE (1992) Am J Physiol 263(2 Pt 1): E345-54
    › Primary publication · 1514617 (PubMed)
65. Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise. Wasserman DH, Mohr T, Kelly P, Lacy DB, Bracy D (1992) Diabetes 41(10): 1229-38
    › Primary publication · 1356861 (PubMed)

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword